Table 2 Relationship between clinicopathologic features and lymph nodes metastases in 90 patients
From: MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison
Parameters | Total (n = 90) | ypN0 (n = 63) | ypN+ (n = 27) | P value |
|---|---|---|---|---|
Age (years) | 55 (24–82)* | 56(27–82) * | 55(24–75) * | 0.926 a |
Sex | 0.830 b | |||
Man | 68 (75.6%) | 48(76.2%) | 20(74.1%) | |
Woman | 22 (24.4%) | 15(23.8%) | 7(25.9%) | |
Tumor location# | 0.777 c | |||
Upper | 11(12.2%) | 7(11.1%) | 4(14.8%) | |
Middle | 51(56.7%) | 35(55.6%) | 16(59.3%) | |
Lower | 28(31.1%) | 21(33.3%) | 7(25.9%) | |
Histological subtype | 0.234 c | |||
Nonmucinous adenocarcinoma | 82(91.1%) | 59(93.7%) | 23(85.2%) | |
Mucinous adenocarcinoma | 8(8.9%) | 4(6.3%) | 4(14.8.%) | |
Differentiation | 0.808 c | |||
Well | 1(1.1%) | 1(1.6%) | 0(0.0%) | |
Moderate | 78(86.7%) | 55(87.3%) | 23(85.2%) | |
Poor | 11(12.2%) | 7(11.1%) | 4(14.8%) | |
ypT stage | 0.004 b | |||
ypT0-2 | 44(48.9%) | 37(58.7%) | 7(25.9%) | |
ypT3-4 | 46(51.1%) | 26(41.3%) | 20(74.1%) |